#ExternalValidity

Matteo Cesarimacesari
2025-09-29

of Patients in Trials Submitted to the Versus Age in Average Patients With

"...Efforts to include more representative study participants in clinical should be intensified..."

agsjournals.onlinelibrary.wile

Jan R. Boehnkejrboehnke
2025-09-03

Thank you to Mona Kanaan (UoYork, UK) for asking me to present in the panel

"From study to target populations: Addressing through the lens of Transportability and Generalisability"
(1:50pm, )

I'll present on 😊

Screenshot from conference programme:

From study to target populations: addressing external validity through the Lens of Transportability and Generalisability
TrackMedical Statistics
Randomised and observational studies each have unique strengths and limitations when estimating causal effects for a target population. While estimates derived from randomised controlled trials may possess internal validity, they often fail to adequately represent the target population due to restrictive inclusion criteria. Observational data are more likely to represent the target population, increasing the likelihood of external validity. However, evidence from observational studies is prone to potential bias due to unmeasured confounding.  A framework has recently been proposed to address the external validity bias through evaluating generalisability and transportability. This session will explore the current developments.
Gaël VaroquauxGaelVaroquaux
2022-12-20

🥁 Reweighting a trial for , the target average treatment is best estimated with covariates = treatment effect modifiers (shifted or not)

Covariates that are shifted between the 2 samples but not treatment effect modifiers increase the variance while non-shifted but treatment effect modifiers do not

4/n

Client Info

Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst